Top Markets
Coin of the day
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rang in Aktien #14294
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Aktienkurs
$17.15
Zuletzt synchronisiert: 2026-08-31
Marktkapitalisierung
$423.01M
Veränderung (1 Tag)
4.67%
Veränderung (1 Jahr)
112.68%
Land
IN
Handel Novartis India Limited (NOVARTIND)

Kategorie

Dividendenrendite-Verlauf für Novartis India Limited (NOVARTIND)
Dividendenrendite (TTM) von Novartis India Limited (Aktienkürzel: NOVARTIND) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Novartis India Limited (NOVARTIND) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber